Dana Rizk, MD - Unlocking the Potential of B-Cell Modulation Therapies in IgA Nephropathy episode artwork

EPISODE · Dec 17, 2024 · 18 MIN

Dana Rizk, MD - Unlocking the Potential of B-Cell Modulation Therapies in IgA Nephropathy

from PeerVoice Internal Medicine Audio · host PeerVoice

Dana Rizk, MD - Unlocking the Potential of B-Cell Modulation Therapies in IgA Nephropathy

Visit https://www.peervoice.com/NEX860 to view the entire programme with slides. After completing “Dana Rizk, MD - Unlocking the Potential of B-Cell Modulation Therapies in IgA Nephropathy”, participants will be able to: Outline the role of Gd-IgA1 and specific immune-mediated mechanisms in the pathophysiology of IgA nephropathy (IgAN); Summarize the relationship between key predictors of long-term outcome and their role in assessing risk of progression in patients with IgAN; Describe the role of different immune-specific targets in IgAN; and Evaluate clinical data regarding therapies targeting immune-specific mediators of disease in patients with IgAN.

NOW PLAYING

Dana Rizk, MD - Unlocking the Potential of B-Cell Modulation Therapies in IgA Nephropathy

0:00 18:50

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of PeerVoice Internal Medicine Audio?

This episode is 18 minutes long.

When was this PeerVoice Internal Medicine Audio episode published?

This episode was published on December 17, 2024.

What is this episode about?

Dana Rizk, MD - Unlocking the Potential of B-Cell Modulation Therapies in IgA Nephropathy

Can I download this PeerVoice Internal Medicine Audio episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!